Shuttle Pharmaceuticals Enters Material Definitive Agreement
Ticker: SHPH · Form: 8-K · Filed: Sep 10, 2024 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Sep 10, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001, $250,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement
TL;DR
Shuttle Pharma signed a big deal on Sept 4th, details TBD.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. entered into a material definitive agreement on September 4, 2024. The filing does not disclose specific details of the agreement or any associated dollar amounts. The company is incorporated in Delaware and its principal executive offices are located in Gaithersburg, MD.
Why It Matters
This filing indicates a significant new agreement for Shuttle Pharmaceuticals, which could impact its future operations and strategic direction. Investors will be looking for more details on the nature and terms of this agreement.
Risk Assessment
Risk Level: medium — The lack of specific details regarding the material definitive agreement introduces uncertainty, warranting a medium risk assessment until more information is disclosed.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- September 4, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Address of principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Shuttle Pharmaceuticals?
The filing states that Shuttle Pharmaceuticals Holdings, Inc. entered into a material definitive agreement on September 4, 2024, but does not provide specific details about the agreement's nature or terms.
When was the material definitive agreement entered into?
The material definitive agreement was entered into on September 4, 2024.
Where are Shuttle Pharmaceuticals Holdings, Inc.'s principal executive offices located?
The principal executive offices of Shuttle Pharmaceuticals Holdings, Inc. are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
In which state is Shuttle Pharmaceuticals Holdings, Inc. incorporated?
Shuttle Pharmaceuticals Holdings, Inc. is incorporated in Delaware.
What is the SEC file number for Shuttle Pharmaceuticals Holdings, Inc.?
The SEC file number for Shuttle Pharmaceuticals Holdings, Inc. is 001-41488.
Filing Stats: 492 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-09-10 17:23:05
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
- $250,000 — e corporation (the "Company"), issued a $250,000 promissory note (the "Promissory Note")
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex10-1.htm (EX-10.1) — 24KB
- 0001493152-24-035667.txt ( ) — 240KB
- shph-20240904.xsd (EX-101.SCH) — 3KB
- shph-20240904_lab.xml (EX-101.LAB) — 33KB
- shph-20240904_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Dated: September 10, 2024 By: /s/ Anatoly Dritschilo Name: Anatoly Dritschilo Title: Chief Executive Officer